tradingkey.logo
tradingkey.logo
Suchen

Inotiv Inc

NOTV
Zur Watchlist hinzufügen
0.080USD
0.0000.00%
Handelsschluss 06/30, 16:00ETKurse um 15 Minuten verzögert
2.79MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Inotiv Inc Unternehmen

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Inotiv Inc Informationen

BörsenkürzelNOTV
Name des UnternehmensInotiv Inc
IPO-datumNov 25, 1997
CEOLeasure (Robert W)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeNov 25
Addresse2701 Kent Ave
StadtWEST LAFAYETTE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl47906-1382
Telefon13174634527
Websitehttps://www.inotiv.com/
BörsenkürzelNOTV
IPO-datumNov 25, 1997
CEOLeasure (Robert W)

Führungskräfte von Inotiv Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
686.00K
-0.88%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
373.36K
-1.44%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
180.99K
-3.19%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+26.21%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+35.76%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
13.20K
-43.94%
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Beth A. Taylor
Ms. Beth A. Taylor
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Mr. David Landman
Mr. David Landman
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
686.00K
-0.88%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
373.36K
-1.44%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
180.99K
-3.19%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+26.21%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+35.76%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
13.20K
-43.94%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Inotiv Inc?

Die fünf größten Anteilseigner von Inotiv Inc sind: Dr. John E. Sagartz, Ph.D.

Wie viele Institutionen halten Anteile an Inotiv Inc (NOTV)?

Mit Stand vom 2026Q1 halten 168 Institutionen Anteile an Inotiv Inc, mit einem Gesamtmarktwert von etwa 8.11M, was 23.58% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -4802422.00 gestiegen.
KeyAI